Company intelligence / Profile preview

RecensMedical

Ulsan, Ulsan, South Korearecensmedical.co.kr ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

The company's precision cooling devices are FDA approved for use in the US as Class II medical devices. They have demonstrated efficacy and safety in reducing pain and improving recovery time for surgical, dermatological, and ophthalmic procedures. Their flagship products include OcuCool for rapid anesthesia during intravitreal injections and TargetCool for broader procedural applications.

Therapeutic areas: OtherDermatologyOphthalmology
Modalities: Device (precision cooling medical devices)
Industry: Surgical Medical Devices

Drug pipeline

2 assets

OcuCool

Commercial

Indications: Ophthalmology

1 more asset in the full pipeline.

Request access →

Partnerships

idsMED distribution partnership in Asia-Pacific region

Beyond the preview

Go deeper on RecensMedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RecensMedical.

Explore the full profile